Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs
about
The emerging role of viral vectors as vehicles for DMD gene editingOncolytic adenovirus-mediated therapy for prostate cancerInitial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.Using the E4orf6-Based E3 Ubiquitin Ligase as a Tool To Analyze the Evolution of Adenoviruses.Getting genetic access to natural adenovirus genomes to explore vector diversity.Vectored immunoprophylaxis: an emerging adjunct to traditional vaccination.Adenovirus coxsackie adenovirus receptor-mediated binding to human erythrocytes does not preclude systemic transduction.Crystal structure of raptor adenovirus 1 fibre head and role of the beta-hairpin in siadenovirus fibre head domains.Advancements in the design and scalable production of viral gene transfer vectors.Viral Vectors, Engineered Cells and the CRISPR Revolution.Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control.Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo.Development of novel vaccine vectors: Chimpanzee adenoviral vectors.Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors.Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor.One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors.
P2860
Q26746647-30E6D0D0-53A8-4139-9EDC-FFD60FEE67D1Q27004796-20A1D2D5-8F98-40A0-A67D-47B5B6B2787AQ36654542-08990AE6-EFAB-40BB-8E43-E77019FF26FAQ37174450-22769CF1-8B8B-402A-B045-D112C4828377Q39437315-B2EDC436-4F01-4107-999D-3E60BBB78B8FQ40040079-6CE04909-B5E7-4F02-9505-EDF0C1479D40Q40526707-B225717B-FE2B-48DD-8724-FFD9591B1F42Q40686770-C709C91D-E9F3-4B5E-9AD0-4E696C4E5C69Q41931475-F8B60F0F-E0B0-4FBB-9C1C-3A5E0B069944Q45874356-65AD1F2D-0710-4E06-B7E0-7418FFA03547Q47547452-4D6D6A0F-1286-47A8-8CA4-ACA78B4BDE1DQ47549105-0F0EC122-8863-4187-AAD6-90BA292A00F3Q47558190-6561A899-71C2-48C1-AF20-40DE4CC5C583Q47558367-CFFC68C6-8124-4CE5-A9C0-2DDD7A1AE019Q47607706-37934C0B-9038-4EFB-A024-FFEDB3421614Q54258996-923EF447-3DEC-4A78-AC6B-AA5F9D85DAABQ55365677-9F0B8625-F6DC-4EDD-936F-D71AC9A3BC11
P2860
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Development of Novel Adenovira ...... d With HAdV-5-based Constructs
@ast
Development of Novel Adenovira ...... d With HAdV-5-based Constructs
@en
Development of Novel Adenovira ...... d With HAdV-5-based Constructs
@nl
type
label
Development of Novel Adenovira ...... d With HAdV-5-based Constructs
@ast
Development of Novel Adenovira ...... d With HAdV-5-based Constructs
@en
Development of Novel Adenovira ...... d With HAdV-5-based Constructs
@nl
prefLabel
Development of Novel Adenovira ...... d With HAdV-5-based Constructs
@ast
Development of Novel Adenovira ...... d With HAdV-5-based Constructs
@en
Development of Novel Adenovira ...... d With HAdV-5-based Constructs
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Development of Novel Adenovira ...... d With HAdV-5-based Constructs
@en
P2093
Andrew H Baker
Angelique Lemckert
Menzo Havenga
Mária Benkő
Tibor Papp
P2860
P3181
P356
10.1038/MT.2015.194
P407
P577
2015-10-19T00:00:00Z